Skip to content

Baxter International BAX Novum LVP Pump — Inventory write-down

Similar metrics at other companies

Globus Medical logo
GMEDInventory write-downs
$4.96M-16.8%
Keysight Technologies logo
KEYSInventory write-downs
$10M-23.1%
Credo Technology Group Holding Ltd logo
CRDOInventory write-downs
$3.29M-8.7%
Ubiquiti Inc. logo
UIInventory write-downs
$168K-95.4%
Ciena logo
CIENInventory write-downs
$20.65M+65.0%
Glaukos logo
GKOSInventory write-downs
$661.25K-40.5%

Other financials

Income statement

See full
Revenue$2.7B+2.9%
Gross profit$891.0M+3.5%
Operating income$66.0M+13.8%
Net income-$15.0M-112%
EPS (diluted)-$0.03-112%

Balance sheet

See full
Cash & equivalents$2.0B-12.1%
Total debt$224.0M-8.9%
Total equity$6.0B-14.7%
Total assets$19.8B-6.8%

Cash flow

See full
Operating cash flow$213.0M+210%
CapEx$128.3M+15.0%
Free cash flow$83.0M-42.1%

Valuation

See full
Market cap$10.27B-50.6%
Enterprise value$8.48B-55.6%
P/S0.9×-1.0×

Profitability

See full
Gross margin30.1%-5.9pp
Operating margin-2.7%
Net margin-9.7%+62.5pp
FCF margin3%-2.4pp

Returns & leverage

See full
Return on equity-16.7%-76.7pp
Debt / equity0.0×
Current ratio1.9×-0.2×

Where this comes from

Reported directly by Baxter International in its filing.

Tagged under the XBRL concept us-gaap:InventoryWriteDown.

The official record: Baxter International’s 10-K, filed February 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Baxter International's novum lvp pump — inventory write-down.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Baxter International's novum LVP pump — inventory write-down?
Baxter International (BAX) reported novum LVP pump — inventory write-down of $26.25M in Q4 2025.
What does novum LVP pump — inventory write-down mean?
This metric represents the accounting charge taken to reduce the carrying value of inventory associated with a specific medical device product line when its market value falls below its cost. It reflects obsolescence, product recalls, or shifts in demand for specialized medical equipment. Monitoring this helps investors assess the lifecycle management and commercial viability of the product segment.